AgeX Therapeutics, Inc.
|Number of Estimates|
AgeX Therapeutics, Inc. operates as a biotechnology company. The firm focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its technology platforms include PureStem, UniverCyte, iTR and HyStem. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
Market Cap: 33.5 Million
Primary Exchange: NYSE American
Shares Outstanding: 37.7 Million
Float: 21 Million
Sector: Health Technology
Industry: Pharmaceuticals: Major
Longest drawdown: 416 trading days
From: 2018-12-03 To: 2020-07-02
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|